Evidence map›Paper›PMID 42066073›Full record

ArticleScience advances2026

Chronic stress disrupts hepatic homeostasis and accelerates liver cancer progression through ADRB2 signaling.

Huimin Qin, Liuwei Chu, Xiaying Zheng, Huimei Zhang, Yue Lan, Ji Hu, Lu Li

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huimin QinSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.ORCID 0009-0009-6941-3704
Liuwei ChuSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.ORCID 0009-0004-7132-5416
Xiaying ZhengPrecision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Huimei ZhangPrecision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.ORCID 0009-0001-6321-8336
Yue LanDepartment of Rehabilitation Medicine, School of Medicine, the Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, Guangdong 510180, China.ORCID 0000-0003-2499-812X
Ji HuSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0001-7930-2316
Lu LiPrecision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.ORCID 0000-0003-4026-7984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic stress has been implicated in the dysregulation of immunological, neurochemical, and endocrinological functions, yet its impact on hepatic homeostasis and liver carcinogenesis remains elusive. In this study, by using single-nucleus RNA sequencing and histopathological evaluation, we demonstrated that chronic stress induced profound hepatic dysfunction. Notably, using orthotopic murine models of liver cancer, we further found that chronic stress substantially accelerated tumor progression. Mechanistically, we identified β2-adrenergic receptor (ADRB2) signaling as the pivotal molecular pathway driving stress-accelerated cancer progression, which was in line with the poor clinical outcomes observed in patients with cancer exhibiting enhanced adrenergic signaling within tumors. Collectively, our study provides compelling evidence that chronic stress compromises hepatic homeostasis and accelerates liver cancer progression via ADRB2 activation, highlighting the therapeutic potential of targeting this pathway and the clinical importance of stress management in hepatic disorders.

Indexed as

HomeostasisLiverLiver NeoplasmsReceptors, Adrenergic, beta-2Signal TransductionStress, PhysiologicalAnimalsDisease Models, AnimalDisease ProgressionHumansMiceADRB2 protein, humanADRB2 protein, mouseReceptors, Adrenergic, beta-2

Identifiers

PMID42066073
PMCPMC13134585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.